“george-scangos” Archives

in
Entry Author Date Location
Genocea CEO Chip Clark to Speak at Xconomy’s April 4 Biotech Forum 03/15/12 Boston
New England’s Emerging Biotech Stars: The Agenda 03/08/12 Boston
How Biogen Idec Overhauled R&D Under Doug Williams 03/07/12 Boston
Disease Foundations Play Growing Role in Biotech Business Model 03/06/12 San Francisco
Why Biogen Idec Got Out of the Corporate VC Business 01/27/12 Boston
New England’s Rising Biotech CEOs to Gather at April 4 Xconomy Event 01/26/12 Boston
Editor’s Picks: Xconomy Boston’s Top 20ish Stories of 2011 12/28/11 Boston
Editor’s Picks: Xconomy Boston’s Top 20 Stories of the Third Quarter 10/28/11 Boston
Portola Grabs $45M Upfront From Biogen Idec to Develop Autoimmune Drugs 10/27/11 San Francisco
Fearless Fantasy Football, Uh, I Mean Biotech, Predictions for the Season Ahead 09/06/11 National
Pfizer Grows in Cambridge, Repligen Eyes Imaging Approval, GI Dynamics Gets Aussie IPO, & More Boston-Area Life Sciences News 09/02/11 Boston
George Scangos, the Boy From Working Class Boston, on His Road Back to Lead Biogen Idec 08/31/11 Boston
Biogen Confirms Cambridge Move, Amag Merges With Allos, ACT Kicks Off Trials, & More Boston-Area Life Sciences News 07/22/11 Boston
Biogen Idec Moving HQ Back to Cambridge, Constructing Two New Buildings at Kendall Square 07/20/11 Boston
Stop the M&A Obsession: Biotech Needs More Companies to Stay Independent 07/18/11 National
Biogen Eyes Cambridge Move, Vertex Licenses Alios Drugs, Concert Nabs GSK Payment, & More Boston-Area Life Sciences News 06/24/11 Boston
Biogen Idec CEO on Move Back to Cambridge: “We’re Working on It” 06/16/11 Boston
Longwood Raises First Fund, Biogen Adds Executives, Boston Scientific Acquires Intellect, & More Boston-Area Life Sciences News 01/07/11 Boston
Biogen Idec’s New R&D Boss, Doug Williams, Spurns Corner Office for a Return to Big Science 01/06/11 Boston
Biogen Idec Nabs Doug Williams as R&D Head, Steve Holtzman as BD Chief To Fill Out Management Team 01/05/11 Boston
Biogen Announces Restructuring, FDA Approves Sunovion Drug, Acceleron Cuts Workforce, & More Boston-Area Life Sciences News 11/05/10 Boston
Biogen Idec Closing San Diego Center, Cadence Wins FDA Approval, Adventrx Files New Drug Application, & More San Diego Life Sciences News 11/04/10 San Diego
Biogen Idec Chief Aims to Make Firm More Like Biotech and Less Like Pharma with Restructuring Plan 11/04/10 Boston
Biogen Idec Axes 650 Jobs, Closes San Diego Site, Bets Future on Neurology 11/03/10 Boston
Exelixis Seeks to Climb From the Penalty Box, Prove its Lead Drug Still Has Legs 10/20/10 San Francisco
5 Biotech Storylines to Watch in Boston 10/13/10 Boston
Exelixis Nabs $60M Upfront, Potentially $505M More, From New Deal With Bristol-Myers 10/11/10 San Francisco
Arena Signs Deal With Eisai for Lorcaserin, Qualcomm CEO Identifies Two Opportunities in Mobile Health, & More San Diego Life Sciences News 07/08/10 San Diego
Exelixis CEO Takes Biogen Gig, What Drives Brook Byers Crazy, The Mission Bay Biotech Cluster, & More Bay Area Life Sciences News 07/02/10 San Francisco
Biogen Names CEO, Glaser Leaves Partners, SV Closes $523M Fund, & More Boston-Area Life Sciences News 07/02/10 Boston
Page 2 of 3 « previous page · next page »